Category: Emerging Markets
Covidien's doubling down in emerging markets yet again, looking to invest in Brazil, South Africa and Mexico and other high-growth regions in hopes of hitting $2 billion in emerging market revenue "as soon as possible."
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Premier Diagnostic Health Services signs a letter of intent with the Beijing branch of Siemens Finance for medical imaging licensing and financing.
Premier Diagnostic, a medical imaging and diagnostic company, signed a letter of intent with Siemens (NYSE:SI) to distribute imaging devices in China. The agreement will provide Premier with lease financing for MRI and PET/CT equipment to open another Center for Advanced Diagnostics in the People's Republic.
Boston Scientific lays out its 5 "strategic imperatives" for driving growth.
Medical device giant Boston Scientific (NYSE:BSX) has been soaring in recent months, with BSX shares up more than 50% since the start of 2013.
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist device.
ALung Technologies said it's pursuing approval from Chinese regulatory authorities for its Hemolung respiratory assist system.
The Pittsburgh-based medical device company said it inked a deal with Curative Medical to seek approval for the Hemolung device from the China Food & Drug Administration.
The hallowed emerging markets in Brazil, Russia, India and China aren't generating the kind of growth once expected for healthcare companies, according to a Frost & Sullivan report.
Emerging markets might not be all they're cracked up to be for healthcare companies, according to a Frost & Sullivan report, as protectionist import policies and competition from generics prove to be big challenges.
Markets the so-called BRIC countries – Brazil, Russia, India and China – aren't proving to be as easy to penetrate as healthcare companies once thought, according to F&S partner Reenita Das.
By Stewart Eisenhart, Emergo Group
The China Food & Drug Administration (CFDA) has announced steps in recent weeks to improve its medical device classification process and ease the path to market for innovative devices.
Electronic validation for CFDA device classifications
Mindray Medical misses 1st-quarter revenue numbers, sending shares down 6.8% on Wall Street before recovering to pre-earnings levels
